Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Industry Insights
  • Page 5

Category: Industry Insights

Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.

Paras Healthcare IPO subscription graphic of a hospital building with eight hospitals
  • Industry Insights

Paras Healthcare IPO Subscription: What Investors Are Buying in the Hospital Group

Megan Wood3 weeks ago010 mins

The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.

Read More
Talkiatry therapy services nationwide graphic with phone and therapy session
  • Industry Insights

Talkiatry Therapy Services Nationwide: What Patients Should Know

Megan Wood3 weeks ago3 weeks ago010 mins

What Talkiatry therapy services nationwide mean for patients on psychiatric medication: coverage, claims, and the questions still unanswered.

Read More
US Ebola travel declaration timeline graphic showing May, July and 3 November steps
  • Industry Insights

US Ebola Travel Declaration: A Timeline of America’s 2026 Entry Rules

Megan Wood4 weeks ago010 mins

The US Ebola travel declaration is the latest step after May and July entry bars. A timeline of the rules, what changes on 3 November and what is unknown.

Read More
Shamonda virus human case public health update graphic
  • Industry Insights

Shamonda Virus Human Case: What French Officials Say and What Comes Next

Megan Wood4 weeks ago010 mins

The Shamonda virus human case in France: official statements, the ECDC comment, the animal context and the open questions investigators are working on.

Read More
Cencora American Oncology Network acquisition layers graphic: physicians, MSO platform, distribution
  • Industry Insights

Cencora Moves to Buy American Oncology Network in Up to $2.4 Billion Deal

Megan Wood4 weeks ago4 weeks ago011 mins

The Cencora American Oncology Network acquisition is valued at up to $2.4 billion. What was disclosed, what was not, and what to watch.

Read More
Graphic: vaccine research ethics shown as a balance scale in purple with gold pans
  • Industry Insights

Vaccine Research Ethics: Lessons From Guinea-Bissau Trial

Megan Wood4 weeks ago4 weeks ago011 mins

Vaccine research ethics under scrutiny after a halted Guinea-Bissau newborn trial: consent, control arms, approvals and what regulators ask.

Read More
Graphic: healthcare company spin-offs shown as a large purple circle with an arrow to a gold circle
  • Industry Insights

Healthcare Company Spin-Offs: What Abbott’s Split Signals

Megan Wood4 weeks ago4 weeks ago010 mins

Healthcare company spin-offs are in focus as Abbott plans to separate nutrition by end-2027. How spin-offs work, and what to read in the filing.

Read More
Graphic: cell and gene therapy manufacturing India shown as three columns under a gold roof
  • Industry Insights

Cell and Gene Therapy Manufacturing India: Nucelion Deal

Megan Wood4 weeks ago4 weeks ago011 mins

Cell and gene therapy manufacturing India: what the Nucelion and VeGen Bio CRDMO deal covers, and what it leaves out, from marketing to the 2028 target.

Read More
Graphic: MMR vaccination shown as a syringe outline beside a green ring
  • Industry Insights

MMR Vaccination Push as Pennsylvania Measles Hits 1,317

Megan Wood4 weeks ago011 mins

MMR vaccination is rising as Pennsylvania measles reaches 1,317 cases: over 56,000 provider doses in September and 10,000 by state nurses.

Read More
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 40

Categories

  • Healthcare IT (26)
  • Industry Insights (355)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
  • Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform
  • Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets
  • Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation
  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.